CNSX:SNN

Smith & Nephew (SNN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
44,398 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SNN stock logo

About Smith & Nephew Stock (CNSX:SNN)

Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.

SNN Stock News Headlines

Smith & Nephew PLC's Dividend Analysis
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Smith & Nephew plans pay rise for US bosses
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?
Smith+Nephew To Buy Agili-C Developer CartiHeal In Up To $330 Mln Deal
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
18,581
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Anthony F. Holler M.D. (Age 71)
    Co-founder, CEO & Chairman
    Comp: $340.63k
  • Dr. Mark Hamish Kimmins (Age 56)
    Pres of NHS
    Comp: $4.68M
  • Mr. David Weinmann
    Global Controller & Interim CFO
  • Rob Knowles
    VP of Corp. Devel.
  • Mr. Jose Calderon
    Head of Grower

SNN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Canopy Growth (WEED), Energous (WATT), Cronos Group (CRON), Aurora Cannabis (ACB), CanniMed Therapeutics (CMED), CannTrust (CTST), CannaRoyalty (CNNRF) and Innovative Industrial Properties (IIPR).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:SNN) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners